These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 33481505)

  • 1. Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
    Chen B; Zhang H; Liu D; Wang X; Ji B; Gao S
    Nucl Med Commun; 2021 May; 42(5):523-527. PubMed ID: 33481505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck.
    Liu Y
    Oral Oncol; 2019 May; 92():46-51. PubMed ID: 31010622
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Cheol Park G; Roh JL; Cho KJ; Seung Kim J; Hyeon Jin M; Choi SH; Yuhl Nam S; Yoon Kim S
    Int J Cancer; 2017 Mar; 140(6):1405-1412. PubMed ID: 27943271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of
    Chaput A; Robin P; Podeur F; Ollivier M; Keromnes N; Tissot V; Nonent M; Salaün PY; Rousset J; Abgral R
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
    Mani N; George MM; Nash L; Anwar B; Homer JJ
    Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical lymph node metastases of squamous cell carcinoma of unknown origin: the diagnostic value of FDG PET/CT and clinical outcome.
    Dale E; Moan JM; Osnes TA; Bogsrud TV
    Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):1015-1019. PubMed ID: 27671150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response evaluation of cervical lymph nodes after chemoradiation in patients with head and neck cancer - does additional [18F]FDG-PET-CT help?
    Dejaco D; Uprimny C; Widmann G; Riedl D; Moser P; Arnold C; Steinbichler TB; Kofler B; Schartinger VH; Virgolini I; Riechelmann H
    Cancer Imaging; 2020 Sep; 20(1):69. PubMed ID: 32993805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Performance of
    Clement C; Leclère JC; Maheo C; Le Pennec R; Le Gal G; Delcroix O; Robin P; Rousset J; Tissot V; Gueguen A; Allio M; Bourbonne V; Schick U; Marianowski R; Salaun PY; Abgral R
    J Nucl Med; 2024 Aug; 65(8):1181-1187. PubMed ID: 38991750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of panendoscopy and positron emission tomography/computed tomography increases detection of unknown primary head and neck carcinoma.
    Sokoya M; Chowdhury F; Kadakia S; Ducic Y
    Laryngoscope; 2018 Nov; 128(11):2573-2575. PubMed ID: 30194842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diffusion-weighted MR imaging and
    Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
    Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
    Han A; Xue J; Hu M; Zheng J; Wang X
    Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occult primary tumors of the head and neck: lack of benefit from positron emission tomography imaging with 2-[F-18]fluoro-2-deoxy-D-glucose.
    Greven KM; Keyes JW; Williams DW; McGuirt WF; Joyce WT
    Cancer; 1999 Jul; 86(1):114-8. PubMed ID: 10391570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of 18F-2-fluoro-2-deoxy-D-glucose PET/computerized tomography on the initial staging and changing the management intent in head and neck squamous cell carcinoma.
    Kandeel A; Saied M; Aldaly M; Darwish H; Alsayed Y
    Nucl Med Commun; 2021 Feb; 42(2):216-224. PubMed ID: 33165255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of FDG PET on the management of occult primary head and neck tumours.
    Wong WL; Saunders M
    Clin Oncol (R Coll Radiol); 2003 Dec; 15(8):461-6. PubMed ID: 14690001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18F-FDG PET in detecting primary site in the patient with primary unknown carcinoma.
    Yabuki K; Tsukuda M; Horiuchi C; Taguchi T; Nishimura G
    Eur Arch Otorhinolaryngol; 2010 Nov; 267(11):1785-92. PubMed ID: 20814690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of PET/CT 3D visualization of head and neck squamous cell carcinoma extended to mandible.
    Lopez R; Gantet P; Julian A; Hitzel A; Herbault-Barres B; Alshehri S; Payoux P
    J Craniomaxillofac Surg; 2018 May; 46(5):743-748. PubMed ID: 29567343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.